AG
ACIU icon

Artal Group’s AC Immune ACIU Stock Holding History

Artal Group’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000,000
Closed -$2.04M – 119
2022
Q4 		$2.04M Hold
1,000,000
– – 0.11% 87
2022
Q3 		$3.16M Hold
1,000,000
– – 0.13% 78
2022
Q2 		$3.61M Hold
1,000,000
– – 0.19% 73
2022
Q1 		$4M Hold
1,000,000
– – 0.17% 90
2021
Q4 		$4.95M Hold
1,000,000
– – 0.13% 104
2021
Q3 		$6.71M Hold
1,000,000
– – 0.15% 100
2021
Q2 		$7.93M Hold
1,000,000
– – 0.16% 100
2021
Q1 		$7.61M Hold
1,000,000
– – 0.13% 111
2020
Q4 		$5.17M Hold
1,000,000
– – 0.11% 106
2020
Q3 		$4.88M Buy
1,000,000
+15,450
+2% +$111K 0.12% 99
2020
Q2 		$6.63M Sell
984,550
-15,450
-2% -$112K 0.19% 90
2020
Q1 		$6.91M Hold
1,000,000
– – 0.29% 59
2019
Q4 		$8.52M Hold
1,000,000
– – 0.33% 52
2019
Q3 		$4.95M Hold
1,000,000
– – 0.2% 73
2019
Q2 		$5.55M Hold
1,000,000
– – 0.22% 73
2019
Q1 		$5.05M Buy
1,000,000
+250,000
+33% +$1.59M 0.21% 74
2018
Q4 		$7.09M Hold
750,000
– – 0.26% 57
2018
Q3 		$6M Buy
750,000
+150,000
+25% +$1.51M 0.16% 69
2018
Q2 		$5.59M Hold
600,000
– – 0.12% 64
2018
Q1 		$6.2M Buy
600,000
+100,000
+20% +$1.22M 0.08% 61
2017
Q4 		$6.4M Hold
500,000
– – 0.1% 60
2017
Q3 		$5.58M Hold
500,000
– – 0.1% 60
2017
Q2 		$4.4M Hold
500,000
– – 0.08% 68
2017
Q1 		$5.18M Buy
500,000
+250,000
+100% +$3.07M 0.12% 59
2016
Q4 		$3.25M Buy
250,000
+100,000
+67% +$1.38M 0.07% 67
2016
Q3 		$2.47M Buy
+150,000
New +$2.59M 0.05% 81

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artal Group's ACIU Position: Q1 2023 in Review

Artal Group sold out of AC Immune (ACIU) in Q1 2023, closing a stake of 1,000,000 shares — an estimated $2.04M sold.

Artal Group first reported a position in ACIU in Q3 2016 and held it in 26 quarters. The position peaked at $8.52M in Q4 2019. 34 funds tracked by Wall St. Rank hold ACIU as of Q1 2023.

  • Artal Group reported no remaining AC Immune position as of Q1 2023 after selling out during the quarter.
  • Artal Group sold 1,000,000 AC Immune shares in Q1 2023, an estimated $2.04M.
  • Artal Group first reported a position in AC Immune in Q3 2016 and held it in 26 quarters.
  • Artal Group's AC Immune position peaked at $8.52M in Q4 2019.
  • 34 funds tracked by Wall St. Rank held AC Immune as of Q1 2023.

Based on Artal Group's 13F filing for Q1 2023, filed 12 May 2023.